Skip to content

Multicenter Liver Cirrhosis Infection Onset and Dynamic follow-up Cohort Study

Multicenter Liver Cirrhosis Infection Onset and Dynamic follow-up Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060875
Enrollment
Unknown
Registered
2022-06-13
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cirrhosis and Infection

Interventions

Sponsors

Tianjin The Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The diagnosis of cirrhosis was made by liver histopathology, or a combination of laboratory biochemistry, radiologic, and endoscopic findings, if a liver biopsy result was not available.

Exclusion criteria

Exclusion criteria: Patients with malignancy or concomitant human immunodeficiency virus infection,or those who received liver transplantation before the study period,or combined with serious extrahepatic diseases, such as chronic renal failure requiring dialysis, serious cardiovascular and cerebrovascular diseases, severe chronic obstructive pulmonary disease and mental diseases and other end-stage diseases were excluded.

Design outcomes

Primary

MeasureTime frame
survival rate;infection rate;

Countries

China

Contacts

Public ContactYing Li

Tianjin The Third Central Hospital

lllyyy5053@126.com+86 13821001022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026